Phase 2 Inflammation Clinical Trials
41 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 41 trials
Recruiting
Phase 2
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
Microvascular Inflammation
Biogen81 enrolled32 locationsNCT07219043
Recruiting
Phase 2
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Obesity and OverweightHIVChronic Inflammation
University of Hawaii12 enrolled1 locationNCT06935838
Recruiting
Phase 2
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
ASCVDVascular InflammationASCVD Management
Massachusetts General Hospital120 enrolled1 locationNCT06691217
Recruiting
Phase 2
Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)
NeuroinflammationTraumatic Brain Injury (TBI) Patients
Lagos State University240 enrolled1 locationNCT07269457
Recruiting
Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
TreatmentDepression, AnxietyAerobic Exercise+2 more
University of Colorado, Denver216 enrolled3 locationsNCT05434130
Recruiting
Phase 2Phase 3
The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.
Axial Spondylarthritis (axSpA)IgG4-related DiseaseInflammation of Unknown Origin+1 more
Universitaire Ziekenhuizen KU Leuven140 enrolled1 locationNCT07535554
Recruiting
Phase 2
Topical Ketotifen 0.25% for Secondary Vestibulodynia
VulvodyniaProvoked VestibulodyniaSecondary Provoked Vestibulodynia+4 more
Center for Vulvovaginal Disorders54 enrolled3 locationsNCT07257029
Recruiting
Phase 2
Reducing Frailty for Older Cancer Survivors Using Supplements II
FrailtyInflammation
University of Rochester118 enrolled1 locationNCT06068543
Recruiting
Phase 2
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Heart FailureInflammation
University of Texas Southwestern Medical Center60 enrolled1 locationNCT06130059
Recruiting
Phase 2
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
Recurrent Grade 3b Follicular LymphomaRefractory Grade 3b Follicular LymphomaRecurrent Transformed Non-Hodgkin Lymphoma+28 more
Mayo Clinic41 enrolled7 locationsNCT06834373
Recruiting
Phase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Phase 1Phase 2
Single and Multiple Ascending Oral Doses of Avenanthramide
Inflammation
Montreal Heart Institute96 enrolled1 locationNCT06101784
Recruiting
Phase 2
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Type 1 DiabetesInsulin SensitivityChronic Inflammation
Asger Lund, MD26 enrolled1 locationNCT07247734
Recruiting
Phase 2Phase 3
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
DepressionAnxietyInflammation+9 more
Cedars-Sinai Medical Center150 enrolled1 locationNCT05552053
Recruiting
Phase 2
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
FatigueInflammation
University of Rochester40 enrolled1 locationNCT06295588
Recruiting
Phase 2
Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants
Very premature infantsPremature infantsInflammation
Monash Medical Centre24 enrolled2 locationsNCT07254000
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 2
Treatment of ARDS With Instilled T3
Lung InflammationARDS, HumanPulmonary Edema+2 more
University of Minnesota68 enrolled2 locationsNCT04115514
Not Yet Recruiting
Phase 2
Efficacy of assigning treatment for participants with VEXAS syndrome with lenzilumab plus azacitidine
V - vacuoles are often seen in cells identified in bone marrow biopsies from patients with VEXAS syndrome.
E - E1 ubiquitin activating enzyme, encoded by the UBA1 gene which is mutated in patients
X - the UBA1 gene is located on the X chromosome.
A - patients have autoinflammation.
S - the mutations are somatic, meaning they are acquired at some point in life and not inherited.
(VEXAS)
South Australian Health & Medical Research Institute Ltd10 enrolled1 locationACTRN12625000619448
Recruiting
Phase 1Phase 2
Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Cardiovascular Diseases (CVD)Kidney Failure, ChronicMalnutrition-Inflammation Syndrome+1 more
Mansoura University46 enrolled1 locationNCT06903559